Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-11 Pepose Jay Director Grant or award +41,143 180,458
2024-06-11 Pepose Jay Director Grant or award · Stock Option (Right to Buy) +35,181 35,181
2024-04-11 Pepose Jay Director Grant or award +32,000 139,315
2024-04-11 Pepose Jay Director Grant or award · Stock Option (right to buy) +48,000 48,000
2024-01-01 Pepose Jay Director Grant or award +14,964 107,315
2023-11-01 Pepose Jay Director Grant or award +35,000 92,351
2023-06-06 Pepose Jay Director Grant or award +10,976 57,351
2023-06-06 Pepose Jay Director Grant or award · Stock Option +9,639 9,639
2023-04-19 Pepose Jay Director Grant or award +468 46,375
2023-01-11 Pepose Jay Director Grant or award +13,013 45,907
2023-01-10 Pepose Jay Director Grant or award · Stock Option (right to buy) +33,291 33,291
2022-07-01 Pepose Jay Director Grant or award +9,900 32,894
2022-06-13 Pepose Jay Director Grant or award · Stock Option (right to buy) +20,000 20,000
2022-04-08 Pepose Jay Director Grant or award · Stock Option (right to buy) +50,000 50,000
2021-12-13 Pepose Jay Director Purchase +8,250 $3.65 $30K 22,994
2021-09-13 Pepose Jay Director Purchase +12,631 $4.75 $60K 14,744
2021-06-07 Pepose Jay Director Grant or award · Stock Option (right to buy) +40,000 40,000

Page 1 of 1 · 17 trades